Interestingly, gene-knockdown experiments on HeLa cells have shown that apoptotic cell death doesn’t rely on p53 status, thus supporting the hypothesis that these complexes might be potent also in p53 deficient cancer cell lines. This evidence concerns the gene TP53 and cancer.